Biogen Pharmachem Industries Ltd () News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 200854, "name": "Biogen Pharma", "stock_name": "Biogen Pharma", "full_name": "Biogen Pharmachem Industries Ltd", "name_url": "stocks-analysis/biogen-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "0.32", "chg": -0.01, "chgp": "-3.03%", "dir": -1, "prev_price": "0.33", "mcapval": "34.00 Cr", "mcap": "Micro Cap", "scripcode": 531752, "symbol": "", "ind_name": "Non Banking Financial Company (NBFC)", "ind_code": 49, "sector_id": 51, "indexname": "India SENSEX", "isin": "INE703D01023", "curr_date": "Jun 29, 04:01 PM", "curr_time": "17:00 PM", "last_traded_at": "Jun 29, 04:01 PM IST", "bse_nse_vol": "76.14 lacs", "exc_status": "Active", "traded_date": "Jun 29, 2026", "traded_date_str": "2026 06 29", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/biogen-pharma-200854-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs031-4077044", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiogenPharmache_priceRelatedfactors_4077044.png", "date": "2026-06-29 10:35:38", "description": "Despite a broadly positive market backdrop with the Sensex gaining 0.17% and several pharma indices hitting new highs, Biogen Pharmachem Industries Ltd has plunged to a fresh 52-week low of Rs.0.31 on 29 Jun 2026, extending its decline amid persistent selling pressure." }, { "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-4061074", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiogenPharmache_mojoScore_4061074.png", "date": "2026-06-18 10:10:34", "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025. However, the analysis and financial metrics discussed below reflect the stock’s current position as of 18 June 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trend, and technical outlook." }, { "title": "Five Consecutive Losses Push Biogen Pharmachem Industries Ltd to a New 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs033-4033744", "imagepath": "https://i.marketsmojo.com/newsimg/2026/6/BiogenPharmache_priceRelatedfactors_4033744.png", "date": "2026-06-03 10:35:07", "description": "" }, { "title": "Biogen Pharmachem Industries Ltd Falls to 52-Week Low of Rs 0.34 as Sell-Off Deepens", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs034-4010497", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_4010497.png", "date": "2026-05-25 10:35:03", "description": "A sharp decline of 8.11% today dragged Biogen Pharmachem Industries Ltd to a fresh 52-week low of Rs 0.34, extending its downward trajectory amid persistent selling pressure despite a broadly positive market backdrop." }, { "title": "Biogen Pharmachem Industries Ltd Drops 9.76%: Valuation Risks and 52-Week Low Mark the Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-drops-976-valuation-risks-and-52-week-low-mark-the-week-4009490", "imagepath": "", "date": "2026-05-24 14:00:56", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>May 18:</strong> Valuation shifts signal heightened risk amidst weak returns</p>\n <p><strong>May 21:</strong> Stock falls to 52-week low of Rs.0.36</p>\n <p><strong>May 22:</strong> Week closes at Rs.0.37 (-0.31%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.0.41</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.0.37</div><div class=\"stat-change negative\">-9.76%</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week..." }, { "title": "Biogen Pharmachem Industries Ltd is Rated Strong Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/biogen-pharmachem-industries-ltd-is-rated-strong-sell-4002822", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_mojoScore_4002822.png", "date": "2026-05-21 10:10:22", "description": "Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and prospects." }, { "title": "Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-to-52-week-low-of-rs036-4002444", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_priceRelatedfactors_4002444.png", "date": "2026-05-21 09:40:43", "description": "" }, { "title": "Biogen Pharmachem Industries Ltd: Valuation Shifts Signal Heightened Risk Amidst Weak Returns", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-valuation-shifts-signal-heightened-risk-amidst-weak-returns-3995843", "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/BiogenPharmache_valuationdot_3995843.png", "date": "2026-05-18 08:00:20", "description": "Biogen Pharmachem Industries Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen a marked deterioration in its valuation metrics, prompting a downgrade to a Strong Sell rating. With its price-to-earnings (P/E) ratio soaring to 45.45 and price-to-book value (P/BV) plummeting to 0.44, the stock’s price attractiveness has shifted from very expensive to risky, raising concerns among investors amid weak returns and poor profitability indicators." }, { "title": "Biogen Pharmachem Industries Ltd Falls 8.89% Amidst Deepening Operational Challenges", "link": "https://www.marketsmojo.com/news/stocks-in-action/biogen-pharmachem-industries-ltd-falls-889-amidst-deepening-operational-challenges-3995575", "imagepath": "", "date": "2026-05-17 14:00:05", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>11 May:</strong> Stock hits 52-week low of Rs.0.43 amid broad market weakness</p>\n <p><strong>13 May:</strong> New 52-week low of Rs.0.42 recorded despite Sensex recovery</p>\n <p><strong>14 May:</strong> Further decline to Rs.0.41, continuing bearish momentum</p>\n <p><strong>15 May:</strong> Stock falls to Rs.0.38, marking a three-day losing streak</p>\n <p><strong>15 May:</strong> Q4 FY26 results reveal mounting losses, signalling operational challenges</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div ..." } ], "total": 103, "sid": "200854", "stock_news_url": "https://www.marketsmojo.com/news/biogen-pharmachem-industries-200854" }, "announcements": [ { "caption": "Closure of Trading Window", "datetime": "12-Jun-2026", "details": "PFA", "source": "BSE" }, { "caption": "Compliances-Reg.24(A)-Annual Secretarial Compliance", "datetime": "23-May-2026", "details": "PFA", "source": "BSE" }, { "caption": "Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011", "datetime": "20-May-2026", "details": "The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for Rama Shiva Lease Finance Pvt Ltd", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "", "data": [ { "txt": "Biogen Pharmachem Industries Ltd has announced <strong>1:6</strong> bonus issue, ex-date: 15 May 26", "dt": "2026-05-15", "middle_text": "Bonus Alert" } ] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

May 18: Valuation shifts signal heightened risk amidst weak returns

May 21: Stock falls to 52-week low of Rs.0.36

May 22: Week closes at Rs.0.37 (-0.31%)

Read full news article

Biogen Pharmachem Industries Ltd is Rated Strong Sell

2026-05-21 10:10:22

Biogen Pharmachem Industries Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 08 Sep 2025, reflecting a significant reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 21 May 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

Markets Rally, But Biogen Pharmachem Industries Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-05-21 09:40:43

Read full news article

Biogen Pharmachem Industries Ltd: Valuation Shifts Signal Heightened Risk Amidst Weak Returns

2026-05-18 08:00:20

Biogen Pharmachem Industries Ltd, a micro-cap player in the Non Banking Financial Company (NBFC) sector, has seen a marked deterioration in its valuation metrics, prompting a downgrade to a Strong Sell rating. With its price-to-earnings (P/E) ratio soaring to 45.45 and price-to-book value (P/BV) plummeting to 0.44, the stock’s price attractiveness has shifted from very expensive to risky, raising concerns among investors amid weak returns and poor profitability indicators.